ArriVent BioPharma, Inc.
ArriVent BioPharma, Inc.
World Rank (Aug-2026)
7575
Market Cap (Aug-2026)
1.455 Billion USD
Headquarters Country
Annual Net Income in USD
-166 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
333 Million USD
Total Liabilities in USD
26 Million USD
Total Equity in USD
307 Million USD
Balance Sheet for Period Ending
As of December-2025
Ads